Skip to main navigation Skip to search Skip to main content

Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient

  • Marcel Lee
  • , Florian Eyer
  • , Norbert Felgenhauer
  • , Hartwig H.F. Klinker
  • , Christoph D. Spinner

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

A 21 year old MSM patient with newly diagnosed HIV infection was hospitalized in our department after ingestion of an overdose of his antiretroviral therapy (ART) comprising dolutegravir (DTG - Tivicay®) and tenofovir disaproxil fumarate/emtricitabine (Truvada®) in suicidal intention. On admission, the patient did not show any clinical signs of intoxication and laboratory findings were unremarkable. After 6 hours of intensive care monitoring, the patient was referred to a psychiatric clinic. 5 days after the day of intoxication, serum creatinine levels increased to high normal values (1.2 mg/dl). However, levels never exceeded the upper threshold. 8 and 12 weeks later, serum creatinine normalized to levels measured prior to the intoxication. No other adverse events occurred, and the patient does not suffer from permanent impairments.

Original languageEnglish
Article number18
JournalAIDS Research and Therapy
Volume12
Issue number1
DOIs
StatePublished - 21 May 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • AIDS
  • Dolutegravir
  • Emtricitabine
  • HIV
  • Overdose
  • Suicide attempt
  • Tenofovir disaproxil fumarate

Fingerprint

Dive into the research topics of 'Overdose of dolutegravir in combination with tenofovir disaproxil fumarate/emtricitabine in suicide attempt in a 21-year old patient'. Together they form a unique fingerprint.

Cite this